Skip to main content
RGNX logo
RGNX
(NASDAQ)
REGENXBIO Inc.
$8.53-- (--)
Loading... - Market loading

REGENXBIO (RGNX) Stock Price & Financial Analysis

REGENXBIO Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$8.10 - $8.68
52-Week High$16.19
52-Week Low$5.04
Open$8.31
Volume419.85K
Average Volume (3M)419.85K
Market Cap439.92M
Shares Outstanding51.57M
Price to Sales (P/S)2.61
Price to Book (P/B)4.33
EV/EBITDA-4.61
Revenue (TTM)170.44M
Net Income (TTM)-193.88M
Free Cash Flow (TTM)-126.38M
EPS (TTM)$-3.75
Profit Margin-113.75%
Operating Margin-94.58%
Return on Equity (ROE)-188.72%
Debt to Equity2.54
50-Day MA$9.54
200-Day MA$10.49
52-Week Change27.66%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About REGENXBIO

What is the current stock price for RGNX?

As of the latest trading session, RGNX stock trades at $8.53. The 52-week range is $5.04–$16.19, with a day range of $8.10–$8.68.

What is the P/E ratio for RGNX?

The P/E ratio (Price-to-Earnings) for RGNX is shown in the Key Statistics section. This valuation metric helps compare REGENXBIO Inc. to industry peers.

Does RGNX pay dividends?

REGENXBIO does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for RGNX?

Based on 4 analysts, the consensus for RGNX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of RGNX?

REGENXBIO's market capitalization is $439.9M, classifying it as a small-cap company. REGENXBIO operates in the Healthcare sector within the Biotechnology industry.